Company Intelligence

FinalDose

FinalDose is building the first programmable drug - a single smart drug molecule that you can insert any diseased genetic code and it can search and destroy cells upon DNA recognition. Unlocking 80% of undruggable targets…

In this profile

Quick Facts

  • Founded 2026
  • Headquarters London, United Kingdom
  • Country United Kingdom
  • Industry AI in Healthcare
  • Company Type Early
  • Status Active
  • Website Official site
  • Last Reviewed Aug 2026

Executive Summary

FinalDose is building the first programmable drug - a single smart drug molecule that you can insert any diseased genetic code and it can search and destroy cells upon DNA recognition. Unlocking 80% of undruggable targets today. Starting with all cancers.

Why It Matters

Programmable DNA drug destroying all cancers, unlocking 80% of targets

Recent Developments

  1. 2026 Company founded

    FinalDose was founded in 2026 per the company profile source on file.

    Source

Connected Reports

Connected Insights

Industries

FinalDose is building the first programmable drug – a single smart drug molecule that you can insert any diseased genetic code and it can search and destroy cells upon DNA recognition. Unlocking 80% of undruggable targets today. Starting with all cancers.

Company information is based on publicly available sources and is reviewed periodically. If you represent this company and would like to request a correction, contact Brel.

Explore Related Intelligence

The AI Brief

Weekly company intelligence in your inbox.

Subscribe